On September 1, 2022 Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, reported that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present in-person at the following investor conferences in New York City (Press release, Geron, SEP 1, 2022, View Source [SID1234618886]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 20th Annual Global Healthcare Conference
Fireside chat on Monday, September 12, 2022, at 5:25 p.m. ET
H.C. Wainwright 24th Annual Global Investment Conference
Corporate presentation on Tuesday, September 13, 2022, at 12:30 p.m. ET
Baird 2022 Global Healthcare Conference
Fireside chat on Wednesday, September 14, 2022, at 1:25 p.m. ET
A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron’s website under Events. Following each scheduled conference event, the related webcast will be archived and available for replay for a period of 30 days.

On September 1, 2022 Cellectis (the "Company") (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, reported that management plans to participate in four upcoming investor conferences (Press release, Cellectis, SEP 1, 2022, View Source [SID1234618885]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the events are below:

Citi’s 17th Annual Biopharma Conference

Format: Panel

Date: September 7th, 2022

Time: 9:40AM- 10:25AM ET

Location: Four Seasons Hotel, Boston, MA

Webcast Link: http://www.veracast.com/webcasts/citigroup/biopharma2022/3DniPm.cfm

Wells Fargo 2022 Healthcare Conference

Format: Investor meetings

Date: September 7-9, 2022

Location: Encore Boston Harbor, Everett, MA

Baird Global Healthcare Conference

Format: Presentation

Date: September 13, 2022

Time: 10:15AM-10:45AM ET

Location: Intercontinental Barclay Hotel, New York City, NY

Jefferies Cell and Genetic Medicine Summit

Format: Presentation

Date: September 29, 2022

Time: Presentation time to be posted on Cellectis.com

Location: Palace Hotel, New York City, NY

Live webcasts and replays of these presentations will be available under the "Events and Webcasts" section on the Investor page of the of the Company’s website: View Source

On September 1, 2022 Abcam plc (Nasdaq: ABCM; AIM: ABC) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, reported that Alan Hirzel, Chief Executive Officer, will be participating in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare conference at the Sheraton, New York Hotel in New York at approximately 4.10 p.m. BST (11.10 a.m. EDT) on 14 September 2022 (Press release, Abcam, SEP 1, 2022, View Source [SID1234618884]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the webcast, please use the following link:

View Source

The live audio webcast will also be available in the investor section of Abcam’s corporate website at corporate.abcam.com/investors/reports-presentations/. An archive will be available after the call at that same address.

On September 1, 2022 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in September (Press release, ORIC Pharmaceuticals, SEP 1, 2022, View Source [SID1234618883]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual Biopharma Conference – Targeted oncology panel discussion on Thursday, September 8, 2022, at 2:40 p.m. ET

Wells Fargo Healthcare Conference – Participating in fireside chat on Friday, September 9, 2022, at 8:35 a.m. ET

H.C. Wainwright 24th Annual Global Investment Conference – Presenting company overview on Monday, September 12, 2022, at 7:00 a.m. ET
Webcasts of the panel discussion and presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.

On September 1, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that it will participate at the H.C. Wainwright 24th Annual Global Investor Conference (Press release, Delcath Systems, SEP 1, 2022, View Source [SID1234618880]). Delcath CEO, Gerard Michel will present on September 12 at 8:30 AM ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. (PRNewsfoto/Delcath Systems, Inc.)

A webcast of the presentation will be available at View Source A replay of the presentation will be available following the event.

Management is scheduled to host one-on-one meetings throughout the event. Investors interested in arranging one-on-one meetings should contact your conference representative. You may also call or email Ben Shamsian of Lytham Partners at 646-829-9701, or [email protected].